Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice-Reference-Cited by-同舟云学术

Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice

Published:2021 Issue:1 Volume:12 Page:293-320
ISSN:2352-345X
Container-title:Cellular and Molecular Gastroenterology and Hepatology
language:en
Short-container-title:Cellular and Molecular Gastroenterology and Hepatology

Author:

Zhou Rongrong,Llorente Cristina,Cao Jinling,Zaramela Livia S.,Zeng Suling,Gao Bei,Li Shang-Zhen,Welch Ryan D.,Huang Feng-Qing,Qi Lian-Wen,Pan Chuyue,Huang Yan,Zhou Pengchen,Beussen Iris,Zhang Ying,Bryam Gregory,Fiehn Oliver,Wang Lirui,Liu E-Hu,Yu Ruth T.,Downes Michael,Evans Ronald M.,Goglin Karrie,Fouts Derrick E.,Brenner David A.,Bode Lars,Fan Xuegong,Zengler Karsten,Schnabl Bernd

Funder

Veterans Health Administration Biomedical Laboratory Research and Development

NIH

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference71 articles.

1. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome;Yki-Jarvinen;Lancet Diabetes Endocrinol,2014

2. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

3. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis;Anstee;Nat Rev Gastroenterol Hepatol,2013

4. NAFLD 2020: the state of the disease;Cotter;Gastroenterology,2020

5. The natural history of nonalcoholic fatty liver disease: a population-based cohort study;Adams;Gastroenterology,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Goblet cells: guardians of gut immunity and their role in gastrointestinal diseases;eGastroenterology;2024-09

2. Insights into the epitranscriptomic role of N6-methyladenosine on aging skeletal muscle;Biomedicine & Pharmacotherapy;2024-08

3. Human milk oligosaccharide 2’-fucosyllactose protects against high-fat diet-induced obesity by changing intestinal mucus production, composition and degradation linked to changes in gut microbiota and faecal proteome profiles in mice;Gut;2024-05-13

4. Impact of gut microbiota on nonalcoholic fatty liver disease: insights from a leave-one-out cross-validation study;Frontiers in Microbiology;2024-01-08

5. Exploring a novel therapeutic strategy: the interplay between gut microbiota and high-fat diet in the pathogenesis of metabolic disorders;Frontiers in Nutrition;2023-12-15